[Alpha-methyl-p-tyrosine suppresses the insomnia following lesion of the raphe system].
D000818:Animals; D001921:Brain / Q000378:metabolism; D001930:Brain Injuries / Q000150:complications*; D001933:Brain Stem / Q000293:injuries*; D002395:Catecholamines / Q000096:biosynthesis; D002415:Cats; D004569:Electroencephalography; D006801:Humans; D012701:Serotonin / Q000378:metabolism; D012890:Sleep / Q000187:drug effects*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy* / Q000209:etiology; D012895:Sleep, REM / Q000187:drug effects; D013238:Stereotaxic Techniques; D014443:Tyrosine / Q000494:pharmacology*; D014446:Tyrosine 3-Monooxygenase
D002395:Catecholamines; D012701:Serotonin; D014443:Tyrosine; D014446:Tyrosine 3-Monooxygenase
L'alpha-méthyl-p-tyrosine supprime l'insomnie consécutive à la lésion du système du raphé.